High-sensitivity MALDI-MRM-MS imaging of moxifloxacin distribution in tuberculosis-infected rabbit lungs and granulomatous lesions.
about
New agents for the treatment of drug-resistant Mycobacterium tuberculosisMass spectrometry imaging of therapeutics from animal models to three-dimensional cell culturesHeterogeneity in tuberculosis pathology, microenvironments and therapeutic responsesNitroimidazoles for the treatment of TB: past, present and futureA medicinal chemists' guide to the unique difficulties of lead optimization for tuberculosisDetermination of [11C]rifampin pharmacokinetics within Mycobacterium tuberculosis-infected mice by using dynamic positron emission tomography bioimaging.Mass spectrometry imaging with high resolution in mass and space.New insights into TB physiology suggest untapped therapeutic opportunitiesDetermination of paclitaxel distribution in solid tumors by nano-particle assisted laser desorption ionization mass spectrometry imagingPharmacokinetics-pharmacodynamics analysis of bicyclic 4-nitroimidazole analogs in a murine model of tuberculosisA multi-scale approach to designing therapeutics for tuberculosisA computational tool integrating host immunity with antibiotic dynamics to study tuberculosis treatmentMass Spectrometry Imaging of Complex Microbial CommunitiesAbsolute Quantitative MALDI Imaging Mass Spectrometry: A Case of Rifampicin in Liver Tissues.Noninvasive determination of 2-[18F]-fluoroisonicotinic acid hydrazide pharmacokinetics by positron emission tomography in Mycobacterium tuberculosis-infected miceMALDI Mass Spectrometry Imaging for Visualizing In Situ Metabolism of Endogenous Metabolites and Dietary PhytochemicalsMatrix-assisted laser desorption ionization imaging mass spectrometry: in situ molecular mapping.Mass Spectrometry Imaging and Structural Analysis of Lipids Directly on Tissue Specimens by Using a Spiral Orbit Type Tandem Time-of-Flight Mass Spectrometer, SpiralTOF-TOF.Limited activity of clofazimine as a single drug in a mouse model of tuberculosis exhibiting caseous necrotic granulomasMALDI imaging techniques dedicated to drug-distribution studies.MALDI imaging mass spectrometry for direct tissue analysis: technological advancements and recent applications.Advanced mass spectrometry technologies for the study of microbial pathogenesis.Nuclear imaging: a powerful novel approach for tuberculosis.Mapping antiretroviral drugs in tissue by IR-MALDESI MSI coupled to the Q Exactive and comparison with LC-MS/MS SRM assay.Single-cell metabolomics: analytical and biological perspectives.A new combination MALDI matrix for small molecule analysis: application to imaging mass spectrometry for drugs and metabolites.MALDI MS imaging as a tool for biomarker discovery: methodological challenges in a clinical setting.Matrix-assisted laser desorption/ionization imaging protocol for in situ characterization of tryptic peptide identity and distribution in formalin-fixed tissue.Quantitative imaging of a therapeutic peptide in biological tissue sections by MALDI MS.Repeat MALDI MS imaging of a single tissue section using multiple matrices and tissue washes.PA-824 is as effective as isoniazid against latent tuberculosis infection in C3HeB/FeJ miceDifferential Mycobacterium bovis BCG vaccine-derived efficacy in C3Heb/FeJ and C3H/HeOuJ mice exposed to a clinical strain of Mycobacterium tuberculosis.Molecular imaging of drug transit through the blood-brain barrier with MALDI mass spectrometry imaging.DMSO-enhanced MALDI MS imaging with normalization against a deuterated standard for relative quantification of dasatinib in serial mouse pharmacology studies.Alternative two-step matrix application method for imaging mass spectrometry to avoid tissue shrinkage and improve ionization efficiency.MALDI mass spectrometry imaging of 1-methyl-4-phenylpyridinium (MPP+) in mouse brain.The path of anti-tuberculosis drugs: from blood to lesions to mycobacterial cells.Using a single, high mass resolution mass spectrometry platform to investigate ion suppression effects observed during tissue imaging.Quantification of small molecule drugs in biological tissue sections by imaging mass spectrometry using surrogate tissue-based calibration standardsAdvances in tissue section preparation for MALDI imaging MS.
P2860
Q26751463-8AE74103-4BB7-4454-BAC6-5A08E258C23CQ26820859-0EFD4A3C-60BA-4EEC-9E6C-D5798248476EQ26823503-7D61E88B-AEEB-4363-8A33-33D3C960212FQ26849554-B11558EA-D13B-4C20-8333-8DE5E87DAD6CQ27004482-B8786893-9AC0-4CD0-96AF-FFEEAA57C2EBQ27324299-95376D41-02EC-4BC1-8CBD-C1B0330E63F1Q28383071-396BBE74-6F46-459D-984D-B8BD2BD991C1Q28388477-0FC15433-6697-4325-A638-55CD53FF9364Q28535605-A42ECE18-92AC-46C0-ADCA-39B3707C9BE6Q28542435-89083D32-44B8-4980-86BB-8A8DFA5435E4Q28647309-22032F77-D7C1-4D24-BF9F-EB9A06D5FBEBQ28649754-7E8954BE-69AD-42E7-AFE7-E09B19647143Q28818798-F10C0A5D-2BDA-439A-AF64-0F5DC6EC1A24Q30371747-ADC8FD79-30F6-42A1-8803-2DFCB53B492AQ30421576-5E2B9606-F178-45FF-8097-6DE7CE322D7DQ30434703-ED44494A-D178-4F0B-9CF3-6225B4896340Q30437243-AB838BE8-8E14-4865-BD0D-4E5A8E6EF1DAQ31146364-7692BDA9-00D9-4004-B858-9E5E2219ABD4Q33798468-D80C100C-6C13-47B0-94DA-36C0313A8FEBQ33934400-EE2AEFED-65C6-4567-A0A3-A4B5CA98921CQ33976656-A402E468-6D10-412F-BC1A-BA3AFF1E373BQ34016892-83E100EE-4587-4F2D-8640-9B01AC12D531Q34315731-32748A45-92B2-4019-A019-B636E2F67A04Q34364249-374437EA-796D-4BFE-BC51-F9BF74BF8C07Q34390082-9CE7F5FE-1F38-4DD8-9EAA-FA215E4C0DA7Q34453929-94D87D8B-4956-49E9-8398-0ECC44E46169Q34454885-4A10BEB0-ADCC-4890-8AA7-8B6220E803AEQ34589419-714EFA79-C50A-4E24-9D33-958C1356366DQ34593213-7DA209B1-A304-45A2-81F5-35FCA566AF12Q34628921-A4A7D243-5189-4F56-8049-F80E3D87B35EQ34633185-FA562FD5-583F-4843-84D1-7BF3361BBBD3Q34784945-279C2C7A-1FE5-4532-9CEA-70E9F12CF368Q35007589-59199552-3CED-481A-8C07-9DF0B2C127D2Q35016405-B6986A71-B987-4F8D-B34B-64D9557AECB2Q35066971-4A0A017E-6AB3-45A0-88FB-1ED86D2CA186Q35069025-F9C1AFCE-2E83-4698-AED3-37D9EE4BEBC7Q35125060-FE4A7FAA-EC2F-44E2-93EC-13176726FE12Q35134075-B28407F6-1C55-42E5-B0B0-BA466D84A6C4Q35149911-5B5879C6-A87B-4085-8A69-65A00D8B6605Q35164791-674B1A7D-44DC-4D15-8989-D6DC2A0934E7
P2860
High-sensitivity MALDI-MRM-MS imaging of moxifloxacin distribution in tuberculosis-infected rabbit lungs and granulomatous lesions.
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
High-sensitivity MALDI-MRM-MS ...... ngs and granulomatous lesions.
@ast
High-sensitivity MALDI-MRM-MS ...... ngs and granulomatous lesions.
@en
type
label
High-sensitivity MALDI-MRM-MS ...... ngs and granulomatous lesions.
@ast
High-sensitivity MALDI-MRM-MS ...... ngs and granulomatous lesions.
@en
prefLabel
High-sensitivity MALDI-MRM-MS ...... ngs and granulomatous lesions.
@ast
High-sensitivity MALDI-MRM-MS ...... ngs and granulomatous lesions.
@en
P2093
P2860
P356
P1433
P1476
High-sensitivity MALDI-MRM-MS ...... ngs and granulomatous lesions.
@en
P2093
Brendan Prideaux
Danielle M Weiner
Dieter Staab
Markus Stoeckli
Véronique Dartois
P2860
P304
P356
10.1021/AC1029049
P407
P577
2011-02-18T00:00:00Z